<DOC>
	<DOCNO>NCT00762281</DOCNO>
	<brief_summary>The purpose study determine whether MEL 80 Excimer Laser effective treatment hyperopia , use part Laser In Situ Keratomileusis ( LASIK ) procedure .</brief_summary>
	<brief_title>Safety Effectiveness Study MEL 80 Excimer Laser Using LASIK Treatment Hyperopia</brief_title>
	<detailed_description>LASIK become one common refractive eye procedure perform country . In hyperopia procedure , steepen occurs corneal surface , rather flattening procedure ( myopic treatment ) . The surgeon produce standard keratomileusis flap use microkeratome , expose corneal stroma . Recontouring flap accomplish removal tissue stroma laser . This recontouring result alter effective lens power central cornea , measure diopter ( D ) . The MEL 80 Excimer Laser System evaluate ability create accurate stable hyperopic refractive correction result .</detailed_description>
	<mesh_term>Hyperopia</mesh_term>
	<criteria>Naturally occur hyperopia +6.0 D , without astigmatism +0.50 D +3.50 D spectacle plane , MRSE ≤ +6.50 D ; Have ≤ 0.75 D latent hyperopia determine difference preoperative MRSE CRSE ; A stable refraction least last 12 month document previous clinical record , i.e. , spherical cylindrical portion manifest refraction progress rate 0.50 D year prior baseline examination eye treat ; Hard contact lens wearer must two central keratometry reading two manifest refraction take least one week apart differ 0.50 D ; Visual acuity correctable least 20/40 eye ; Operative eye must target emmetropia ; At least 21 year age ; Willing able return schedule follow examination 24 month surgery ; Sign give copy write Informed Consent form . A history anterior segment pathology , include cataract ( operative eye ) ; Severe dry eye syndrome unresolved treatment ; Residual , recurrent , active ocular uncontrolled eyelid disease , corneal scar within ablation zone corneal abnormality recurrent corneal erosion severe basement membrane disease ; Ophthalmoscopic sign keratoconus ( keratoconus suspect ) ; An ablation deeper 250 micron corneal endothelium ; Irregular unstable ( distorted/not clear ) corneal mire central keratometry reading ; Blind fellow eye ; Undergone previous intraocular corneal surgery kind operative eye ( ) , include type excimer laser surgery either refractive therapeutic purpose ; A history ocular Herpes zoster Herpes simplex keratitis ; A history steroidresponsive rise intraocular pressure , glaucoma , preoperative IOP &gt; 21 mm Hg ; Diabetes , diagnose autoimmune disease , connective tissue disease , clinically significant atopic syndrome ; Immunocompromised use chronic systemic corticosteroid immunosuppressive therapy ; Pregnant , lactating , childbearing potential practicing medically approve method birth control ; A know sensitivity plan study medication ; Participating ophthalmic drug device clinical trial time clinical investigation ; At risk angle closure develop strabismus postoperatively . For Fellow ( Second ) Eyes Simultaneous Bilateral Treatment Procedures 1 . Flap complication first eye 's surgery free cap , partial flap , thin flap , irregular flap . 2 . Epithelial defect exceed 2 mm x 2 mm dimension , clinically significant debris interface flap underlie stroma first eye . 3 . Severe blepharospasm first eye may prevent impeded completion keratectomy and/or laser ablation procedure . 4 . Poor subject cooperation instruction first eye 's surgery and/or poor subject fixation laser fixation target . 5 . Aborted LASIK procedure first eye PRK perform first eye LASIK possible .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>Hyperopia</keyword>
	<keyword>Laser In Situ Keratomileusis</keyword>
	<keyword>Laser Therapy</keyword>
	<keyword>Laser Corneal Surgery</keyword>
	<keyword>Refractive Surgical Procedures</keyword>
	<keyword>Ophthalmologic Surgical Procedure</keyword>
	<keyword>Operative Surgical Procedures</keyword>
	<keyword>Therapeutics</keyword>
</DOC>